C. Manegold

3.6k citations
68 papers · 2.7k · 1 hit paper · h-index 24

Impact in

    • Lung Cancer Treatments and Mutations
    • Occupational and environmental lung diseases
    • Lung Cancer Diagnosis and Treatment
    • Pleural and Pulmonary Diseases
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Oncology top 5%
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies

Papers in

    • Lung Cancer Treatments and Mutations 22
    • Lung Cancer Diagnosis and Treatment 15
    • Occupational and environmental lung diseases 10
    • Pleural and Pulmonary Diseases 5
    • Medical Imaging and Pathology Studies 4
    • Lung Cancer Research Studies 12

C. Manegold

62 papers receiving 2.5k citations

C. Manegold's Hit Papers

Overall survival with cisplatin–gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL) 2010 · 529 citations
5290+5+10Years since publication100200300400500

Peers

C. Manegold
Comparison fields: 5 of 107
  • Pulmonary and Respiratory Medicine 1.2k
  • Oncology 728
  • Clinical Biochemistry 180
  • Biochemistry 85
  • Neurology 143
Replace Kota Ishizawa with:
Kota Ishizawa Japan
Heinz Linhart Germany
Hisao Imai Japan
Shigenobu Suzuki Japan
Bouke P. C. Hazenberg Netherlands
Rosana Eisenberg United States
Luca Porcu Italy
Bernard Malavaud France
Kirk Nicholas Campbell United States
Jan Koudstaal Netherlands
C. Manegold relative to Kota Ishizawa Japan Kota Ishizawa's profile →
Citations per field
00.5×2×3×4.0×
Kota Ishizawa · 1×
Citations per year

Countries citing papers authored by C. Manegold

Since Specialization
Citations

This map shows the geographic impact of C. Manegold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Manegold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Manegold more than expected).

Fields of papers citing papers by C. Manegold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Manegold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Manegold. The network helps show where C. Manegold may publish in the future.

Co-authors

The 25 scholars most cited alongside C. Manegold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. Manegold Line = papers co-authored together C. Manegold links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Overall survival with cisplatin–gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)
Hit paper breakdown →
2010529
2 2010185
3 2006167
4 2000131
5 2005131
6 2002128
7 2011121
8 2008114
9 2011105
10 200399
11 200998
12 201085
13 201377
14 197974
15 200557
16 200351
17 201351
18 200944
19 200437
20 201229

About C. Manegold

C. Manegold is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Neurology, Pathology and Forensic Medicine and Clinical Biochemistry, having authored 68 papers that have together received 2.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (22 papers), Lung Cancer Diagnosis and Treatment (15 papers), Lung Cancer Research Studies (12 papers), Occupational and environmental lung diseases (10 papers), Pleural and Pulmonary Diseases (5 papers), Medical Imaging and Pathology Studies (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.2k citations), Oncology (728 citations), Clinical Biochemistry (180 citations), Biochemistry (85 citations) and Neurology (143 citations). C. Manegold has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Joachim von Pawel, Martin Reck, Petr Zatloukal, Rodryg Ramlau, Venice Rosalie Archer, N. B. Leighl, Jörg Michael Mezger, Vera Hirsh, V. Gorbounova and Norman C. Moore. Their work appears in journals such as Annals of Oncology, Lung Cancer, European Journal of Cancer, British Journal of Cancer and Seminars in Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact